INCYTE CORPORATION Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INCYTE CORPORATION stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-06-30 was 261.76K shares, a 10.27% decline year-over-year.
- INCYTE CORPORATION stock issued during period, shares, employee stock purchase plans for the quarter ending 2024-06-30 was 291.74K shares, a 34.96% increase year-over-year.
- INCYTE CORPORATION stock issued during period, shares, employee stock purchase plans for the quarter ending 2023-06-30 was 216.17K shares, a 13.96% increase year-over-year.
- INCYTE CORPORATION stock issued during period, shares, employee stock purchase plans for the quarter ending 2022-06-30 was 189.68K shares, a 23.91% increase year-over-year.
- INCYTE CORPORATION stock issued during period, shares, employee stock purchase plans for fiscal 2025 was 398.37K shares, a 12.12% decline from fiscal 2024.
- INCYTE CORPORATION stock issued during period, shares, employee stock purchase plans for fiscal 2024 was 453.31K shares, a 19.25% increase from fiscal 2023.
- INCYTE CORPORATION stock issued during period, shares, employee stock purchase plans for fiscal 2023 was 380.14K shares, a 23.26% increase from fiscal 2022.
- INCYTE CORPORATION stock issued during period, shares, employee stock purchase plans for fiscal 2022 was 308.41K shares, a 16.60% increase from fiscal 2021.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2025-12-31 | 398.37K shares 10-K · filed 2026-02-10 | |
| 2025-06-30 | 261.76K shares 10-Q · filed 2025-10-28 | |
| 2024-12-31 | 453.31K shares 10-K · filed 2026-02-10 | |
| 2024-06-30 | 291.74K shares 10-Q · filed 2025-10-28 | |
| 2023-12-31 | 380.14K shares 10-K · filed 2026-02-10 | |
| 2023-06-30 | 216.17K shares 10-Q · filed 2024-10-29 | |
| 2022-12-31 | 308.41K shares 10-K · filed 2025-02-10 | |
| 2022-06-30 | 189.68K shares 10-Q · filed 2023-10-31 | |
| 2021-12-31 | 264.50K shares 10-K · filed 2024-02-13 | |
| 2021-06-30 | 153.08K shares 10-Q · filed 2022-11-01 | |
| 2020-12-31 | 258.45K shares 10-K · filed 2023-02-07 | |
| 2020-06-30 | 175.62K shares 10-Q · filed 2021-11-02 | |
| 2019-12-31 | 239.59K shares 10-K · filed 2022-02-08 | |
| 2019-06-30 | 143.38K shares 10-Q · filed 2020-11-05 | |
| 2018-12-31 | 233.71K shares 10-K · filed 2021-02-09 | |
| 2018-06-30 | 150.54K shares 10-Q · filed 2019-10-29 | |
| 2017-12-31 | 157.28K shares 10-K · filed 2020-02-13 | |
| 2016-12-31 | 126.65K shares 10-K · filed 2019-02-14 | |
| 2015-12-31 | 194.45K shares 10-K · filed 2018-02-15 | |
| 2014-12-31 | 193.66K shares 10-K · filed 2017-02-14 | |
| 2013-12-31 | 390.00K shares 10-K · filed 2016-02-12 | |
| 2012-12-31 | 378.04K shares 10-K · filed 2015-02-17 | |
| 2011-12-31 | 896.94K shares 10-K · filed 2014-02-21 | |
| 2010-12-31 | 1.18M shares 10-K · filed 2013-02-21 | |
| 2009-12-31 | 748.56K shares 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |